Market Exclusive

INOGEN, INC. (NASDAQ:INGN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

INOGEN, INC. (NASDAQ:INGN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Scott Wilkinson

Chief Executive Officer and President

$

415,000

$

499,000

Alison Bauerlein

Executive Vice President, Finance,

$

340,000

$

355,000

Chief Financial Officer, Corporate

Secretary and Corporate Treasurer

Matthew Scribner

Executive Vice President, Operations

$

295,000

$

303,000

Brenton Taylor

Executive Vice President, Engineering

$

300,000

$

310,000

(1) Base salary increases are effective as of February 12, 2018.

About INOGEN, INC. (NASDAQ:INGN)
Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.

Exit mobile version